SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Pheast Therapeutics to Present Preclinical Data on PHST001 at SITC Annual Meeting

Pheast Therapeutics announced an upcoming poster presentation of preclinical data on PHST001 at the 41st Society for Immunotherapy of Cancer (SITC) Annual Meeting.